Skip to main content
. Author manuscript; available in PMC: 2010 Jul 15.
Published in final edited form as: J Cardiovasc Pharmacol. 2009 Jul;54(1):47–56. doi: 10.1097/FJC.0b013e3181ab371d

TABLE 1.

Hemodynamic, Echocardiographic, and Other Parameters for DS Rats in the 5 Experimental Groups at 19 Weeks of Age

Parameter Control HF HYD OLM + AZE APO
Body weight (g) 417 ± 16 376 ± 24 406 ± 17 412 ± 19 401 ± 21
Heart rate (bpm) 416 ± 12 478 ± 23 501 ± 16 426 ± 18 450 ± 16
SBP (mm Hg) 151 ± 4 229 ± 3* 205 ± 208 208 ± 5 217 ± 6
LVW:BW (mg/g) 2.2 ± 0.1 3.5 ± 0.3* 2.7 ± 0.2 2.4 ± 0.2 2.8 ± 0.3
Lung weight (wet/dry) 4.2 ± 0.3 6.7 ± 0.5* 5.2 ± 0.4 4.3 ± 0.3 4.9 ± 0.4
IVST (mm) 1.4 ± 0.1 2.1 ± 0.1* 1.7 ± 0.1 1.6 ± 0.1 1.8 ± 0.1
LVDd (mm) 7.1 ± 0.1 9.4 ± 0.4* 8.1 ± 0.2 7.4 ± 0.2 8.2 ± 0.3
LVFS (%) 46 ± 1 34 ± 2* 43 ± 1 48 ± 2 41 ± 1
dp/dtmax (mm Hg/s) 9284 ± 1124 7127 ± 927* 9467 ± 2034 11,990 ± 1113 10,132 ± 2314
dp/dtmin (mm Hg/s) 12,167 ± 1466 7796 ± 1019* 9039 ± 2405* 13,167 ± 917 10,800 ± 2014*
T1/2 (ms) 3.4 ± 0.1 5.5 ± 0.2* 4.9 ± 0.3* 3.7 ± 0.2 4.4 ± 0.2*
LVEDP (mm Hg) 4.8 ± 0.5 16.5 ± 1.5* 14.5 ± 1.4* 6.9 ± 0.5 9.3 ± 1.5*
Elastolytic activity 450 ± 56 1980 ± 134* 1810 ± 201* 750 ± 88 1259 ± 109
Ang II (pg/mg LVW) 155 ± 13 360 ± 43* 346 ± 51* 178 ± 45 308 ± 65*

Elastolytic activity is expressed in fluorescence units. Data are means ± SEM for at least 6 animals of each group.

*

P < 0.05 versus control group;

P < 0.05,

P < 0.01 versus HF group.

Ang II, angiotensin II; BW, body weight; IVST, interventricular septum; LVEDP, left ventricular end-diastolic pressure; LVFS, left ventricular fractional shortening; LVW, left ventricular weight; SBP, systolic blood pressure.